Celcuity Stock (NASDAQ:CELC), Quotes and News Summary

Q: What sector and industry does Celcuity (CELC) operate in?

Celcuity is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Celcuity Stock (NASDAQ: CELC) stock price, news, charts, stock research, profile.

Open	$17.060
Close	$16.940
Volume / Avg.	90.283K / 217.854K
Day Range	16.910 - 17.270
52 Wk Range	8.389 - 22.188
Market Cap	$515.876M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	40
Short Interest	7.21%
Days to Cover	6.88

Recent News

10 Short Squeeze Stocks To Watch: Yellow Corporation, Getty Images, Tupperware And More

Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a new focus of traders looking for the next huge move. High short interest and steep borrowing costs are among the common traits that could lead to a short squeeze.

Chris Katje

Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session

Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.

Lisa Levin

The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings

Here's a roundup of top developments in the biotech space over the last 24 hours:

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Dec 23

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Celcuity Inc

Sector

Health Care

Industry

Biotechnology

Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Compan...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Celcuity (CELC) stock?

You can purchase shares of Celcuity (NASDAQ: CELC) through any online brokerage.

View our list of the best stock brokerages.

Who are Celcuity's (CELC) competitors?

Other companies in Celcuity’s space includes: KalVista Pharma (NASDAQ:KALV), Humacyte (NASDAQ:HUMA), Valneva (NASDAQ:VALN), Altimmune (NASDAQ:ALT) and Fate Therapeutics (NASDAQ:FATE).

What is the target price for Celcuity (CELC) stock?

The latest price target for Celcuity (NASDAQ: CELC) was reported by Needham on Friday, April 12, 2024. The analyst firm set a price target for 24.00 expecting CELC to rise to within 12 months (a possible 41.68% upside). 10 analyst firms have reported ratings in the last year.

Current Stock Price for Celcuity (CELC)?

The stock price for Celcuity (NASDAQ: CELC) is $16.94 last updated April 24, 2024 at 4:02 PM EDT.

Does Celcuity (CELC) pay a dividend?

There are no upcoming dividends for Celcuity.

When is Celcuity (NASDAQ:CELC) reporting earnings?

Celcuity’s Q1 earnings are confirmed for Monday, May 13, 2024.

Is Celcuity (CELC) going to split?

There is no upcoming split for Celcuity.

What sector and industry does Celcuity (CELC) operate in?

Celcuity is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-